NCT01887340View on ClinicalTrials.gov

Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

271

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2026

Conditions
Seminoma
Interventions
DRUG

Carboplatin

"\- carboplatine: Dose (mg) = AUC x (GFR + 25)~* GFR : glomérulaire filtration (ml/min)~* AUC : area under curve (mg/ml x min)"

DRUG

Etoposide

100 mg/m2 D1 to D5

DRUG

Cisplatin

20 mg/m2 de D1 to D5

Trial Locations (1)

94805

RECRUITING

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER